Israel Englander’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60.5M Sell
254,734
-424,949
-63% -$88.3M 0.02% 783
2026
Q1
$144M Buy
679,683
+275,278
+68% +$59.3M 0.06% 309
2025
Q4
$83.1M Sell
404,405
-1,580,019
-80% -$297M 0.03% 511
2025
Q3
$311M Buy
1,984,424
+706,689
+55% +$109M 0.13% 98
2025
Q2
$215M Sell
1,277,735
-128,254
-9% -$19M 0.1% 154
2025
Q1
$194M Sell
1,405,989
-1,990,235
-59% -$254M 0.1% 162
2024
Q4
$402M Buy
3,396,224
+2,608,333
+331% +$305M 0.2% 61
2024
Q3
$87.1M Sell
787,891
-11,248
-1% -$1.18M 0.04% 502
2024
Q2
$78.6M Buy
799,139
+238,833
+43% +$24.3M 0.04% 529
2024
Q1
$62.7M Sell
560,306
-400,235
-42% -$43.2M 0.03% 694
2023
Q4
$96.8M Buy
960,541
+32,384
+3% +$3.21M 0.04% 438
2023
Q3
$80.6M Buy
928,157
+402,511
+77% +$36.4M 0.04% 463
2023
Q2
$49.7M Buy
525,646
+182,205
+53% +$15.4M 0.02% 741
2023
Q1
$25.9M Sell
343,441
-216,841
-39% -$16.4M 0.01% 1152
2022
Q4
$43.1M Sell
560,282
-268,929
-32% -$20.4M 0.02% 845
2022
Q3
$55.3M Sell
829,211
-1,535,372
-65% -$97.3M 0.03% 628
2022
Q2
$124M Buy
2,364,583
+1,456,445
+160% +$82.8M 0.08% 207
2022
Q1
$51.5M Sell
908,138
-254,763
-22% -$13.6M 0.03% 673
2021
Q4
$59.9M Sell
1,162,901
-602,007
-34% -$29.5M 0.03% 622
2021
Q3
$87.3M Buy
1,764,908
+713,539
+68% +$38.7M 0.05% 366
2021
Q2
$60M Buy
1,051,369
+929,318
+761% +$54.3M 0.04% 519
2021
Q1
$7.42M Sell
122,051
-822,681
-87% -$45.4M 0.01% 2124
2020
Q4
$50.6M Sell
944,732
-465,833
-33% -$24.2M 0.04% 452
2020
Q3
$66.2K Buy
1,410,565
+453,707
+47% +$23.3M 0.08% 223
2020
Q2
$49.9M Buy
956,858
+262,611
+38% +$13.5M 0.07% 288
2020
Q1
$33.3M Buy
694,247
+329,244
+90% +$17.1M 0.07% 269
2019
Q4
$18.5M Buy
+365,003
New +$18.9M 0.02% 903
2019
Q3
Sell
-721,475
Closed -$32.9M 4189
2019
Q2
$34M Buy
721,475
+712,037
+7,544% +$32.8M 0.05% 498
2019
Q1
$454K Sell
9,438
-1,265,869
-99% -$63.4M ﹤0.01% 3329
2018
Q4
$56.9M Sell
1,275,307
-288,290
-18% -$15M 0.09% 298
2018
Q3
$84.4M Sell
1,563,597
-455,717
-23% -$23.3M 0.1% 237
2018
Q2
$98.6M Buy
2,019,314
+1,999,343
+10,011% +$113M 0.13% 192
2018
Q1
$1.25M Sell
19,971
-162,010
-89% -$11.1M ﹤0.01% 2580
2017
Q4
$11.2M Sell
181,981
-74,282
-29% -$4.59M 0.02% 1255
2017
Q3
$17.1M Buy
+256,263
New +$18.1M 0.03% 880
2017
Q1
Sell
-43,750
Closed -$3.15M 3508
2016
Q4
$3.15M Sell
43,750
-191,216
-81% -$13.8M 0.01% 1620
2016
Q3
$18.3M Buy
234,966
+21,239
+10% +$1.72M 0.03% 620
2016
Q2
$16.7M Buy
+213,727
New +$17M 0.04% 612
2016
Q1
Sell
-73,457
Closed -$6.56M 3276
2015
Q4
$6.56M Sell
73,457
-476,238
-87% -$40.4M 0.01% 1181
2015
Q3
$42.2M Buy
549,695
+6,769
+1% +$566K 0.08% 284
2015
Q2
$45.4M Buy
542,926
+242,985
+81% +$21.5M 0.09% 284
2015
Q1
$27.1M Sell
299,941
-466,651
-61% -$40.2M 0.05% 509
2014
Q4
$61.9M Buy
+766,592
New +$60.5M 0.13% 166
2014
Q3
Sell
-347,412
Closed -$23.8M 3705
2014
Q2
$23.8M Sell
347,412
-259,708
-43% -$17.7M 0.07% 398
2014
Q1
$42.5M Buy
607,120
+57,009
+10% +$3.96M 0.12% 182
2013
Q4
$36.8M Buy
550,111
+199,174
+57% +$12.2M 0.12% 162
2013
Q3
$18.3M Sell
350,937
-14,795
-4% -$752K 0.06% 387
2013
Q2
$17.3M Buy
+365,732
New +$16.7M 0.05% 367

Other funds holding CAH

Israel Englander's CAH Position: Q2 2026 in Review

Israel Englander reduced its Cardinal Health (CAH) stake by 63% in Q2 2026, selling an estimated $88.3M and leaving 254,734 shares worth $60.5M. The position accounts for 0.02% of the portfolio, ranked #783.

Israel Englander first reported a position in CAH in Q2 2013 and has held it in 48 quarters since. The position peaked at $402M in Q4 2024. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Israel Englander held 254,734 shares of Cardinal Health worth $60.5M as of Q2 2026.
  • Israel Englander sold 424,949 Cardinal Health shares in Q2 2026, an estimated $88.3M.
  • Cardinal Health made up 0.02% of Israel Englander's portfolio in Q2 2026, its #783 holding.
  • Israel Englander first reported a position in Cardinal Health in Q2 2013 and has held it in 48 quarters since.
  • Israel Englander's Cardinal Health position peaked at $402M in Q4 2024.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.